Trident Lifeline's stock is currently trading at Rs. 321.00, marking an increase of 3.00 points or 0.94% from its last closing price of Rs. 318.00 on the BSE.

The stock began trading today at Rs. 304.00 and reached a high of Rs. 321.00 and a low of Rs. 302.55. A total of 45,000 shares have been exchanged so far.

Classified under the BSE 'MT' group with a face value of Rs. 10, the stock hit a 52-week high of Rs. 339.00 on September 5, 2024, and a 52-week low of Rs. 136.00 on March 19, 2024.

Over the past week, the stock reached a high of Rs. 332.00 and a low of Rs. 302.55. The company's current market capitalization stands at Rs. 369.12 crore.

The company's promoters hold 65.51% of the shares, while institutions and non-institutional investors own 6.02% and 28.47%, respectively.

Trident Lifeline has commenced commercial production at its newly established manufacturing facility in Talangpor, Chorasi, Surat, Gujarat, effective from September 12, 2024. The new plant has a production capacity of 50,000 syrup bottles and 50,000 ointments per day.

Trident Lifeline specializes in the production and marketing of high-quality finished dosage forms.